Now showing items 1-5 of 5
Development and Testing of a Framework for the Assessment of Health-Related Risks Among Travellers by Pharmacists in Ontario
(University of Waterloo, 2019-12-18)
As pharmacists move away from traditional dispensary roles and towards more clinical services, a therapeutic realm that pharmacists are exploring is travel medicine. However, travel medicine can be challenging to beginners ...
Ethynyl-1,1’-Biphenyl Derivatives as Amyloid Beta Aggregation Inhibitors
(University of Waterloo, 2019-12-19)
Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder, with characteristic symptoms including memory loss and cognitive decline. AD is characterized by the formation of dense amyloid β (Aβ) plaques and ...
Health and Economic Impact of Treatment-based Strategies on Chronic Hepatitis B in Ontario
(University of Waterloo, 2019-08-23)
Background/Aim: The lives of about 257 million people in the world are being affected by chronic hepatitis B (CHB), and this contagious disease is gradually pushing them closer to the edge of death caused by cirrhosis and ...
Cell Density-Dependent Changes in the Localization of the CD26 Protein in Colorectal Cancer Cells in Response to Flavonoid Treatment
(University of Waterloo, 2019-05-24)
Colorectal cancer is the 3rd most common cancer worldwide and this rate of incidence is largely attributable to lifestyle factors such as the diet. A group of plant secondary metabolites called flavonoids has been found ...
Characterization of Bacteriophage λ Displaying Epidermal Growth Factor in the Uptake, Infiltration and Formation of HT29 Spheroids
(University of Waterloo, 2019-07-31)
Solid tumours are characterized by a complex structure comprised of extracellular matrix, neoplastic cells and stromal cells, each presenting a barrier to conventional anticancer chemotherapy as well as carrier-mediated ...